This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
AMREP Stock Price Dips Despite FY25 Earnings Rise and Strong Margins
by Zacks Equity Research
AXR's earnings nearly doubled in fiscal 2025 on strong margins and cost cuts amid overall revenue decline.
The Zacks Analyst Blog Highlights NVIDIA, Netflix, Goldman Sachs and AMREP
by Zacks Equity Research
NVDA, NFLX, GS, and AXR stand out with strong performance and growth drivers, despite margin or macro risks.
Top Research Reports for NVIDIA, Netflix & Goldman Sachs
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA, Netflix, and Goldman Sachs, as well as a micro-cap stock, AMREP.
The Zacks Analyst Blog Highlights Visa, Johnson & Johnson, Thermo Fisher and AMREP
by Zacks Equity Research
Visa, Johnson & Johnson, Thermo Fisher and AMREP are included in this Analyst Blog.
Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and Thermo Fisher Scientific Inc. (TMO), as well as a micro-cap stock AMREP Corporation (AXR).
AXR Earnings Rise in Q3, Stock Declines Amid Land Sale Slowdown
by Zacks Equity Research
AMREP's Q3 fiscal 2025 earnings, but revenue falls as land sales slow down. Despite strong homebuilding growth, the stock declines amid market challenges.
The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP
by Zacks Equity Research
Berkshire Hathaway, The Home Depot, Pfizer and AMREP are included in this Analyst Blog.
Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), The Home Depot, Inc. (HD) and Pfizer Inc. (PFE), as well as a micro-cap stock AMREP Corporation (AXR).
AXR Stock Dips After Reporting Q2 Earnings, Revenues Surge Y/Y
by Zacks Equity Research
AMREP posts strong revenue growth in second-quarter fiscal 2025, driven by strong land and home sales, but rising costs and market challenges weigh on the outlook.
2 Small Caps: Should You Bet the "House"?
by Mark Zinski
HOV and AXR are two housing plays approaching different geographical markets.
The Zacks Analyst Blog Highlights SAP, Goldman Sachs, Lockheed Martin, AMREP and Nova LifeStyle
by Zacks Equity Research
SAP, Goldman Sachs, Lockheed Martin, AMREP and Nova LifeStyle are included in this Analyst Blog.
Top Analyst Reports for SAP, Goldman Sachs & Lockheed Martin
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), The Goldman Sachs Group, Inc. (GS) and Lockheed Martin Corp. (LMT), as well as two micro-cap stocks AMREP Corp. (AXR) and Nova LifeStyle, Inc. (NVFY).
AXR Stock Flat Despite Q1 Earnings Surge, Improvement in Revenues
by Zacks Equity Research
AMREP's overall top line benefits from growth in all the revenue sources.
Zacks Initiates Coverage of AMREP With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates AMREP as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore AXR's strategic positioning and financial health amid market challenges.
The Zacks Analyst Blog Highlights Costco, Danaher, ServiceNow, AMREP and Autoscope
by Zacks Equity Research
Costco, Danaher, ServiceNow, AMREP and Autoscope are included in this Analyst Blog.
Top Stock Reports for Costco, Danaher & ServiceNow
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), Danaher Corporation (DHR) and ServiceNow, Inc. (NOW), as well as two micro-cap stocks AMREP Corporation (AXR) and Autoscope Technologies Corporation (AATC).
AMREP (AXR) FY24 Earnings Decline, Revenues Record Improvement
by Zacks Equity Research
AMREP's (AXR) overall top line benefits from revenue growth in the majority of the revenue sources.